Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Abdominal Cancer × Influenza Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Influenza, Human 13 Neoplasms 6 Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Colorectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia 2 Central Nervous System Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vaccine-Preventable Diseases 1 Vaccination Hesitancy 1 Skin Neoplasms 1 Serology Analysis 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Patient Acceptance of Health Care 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Older Patients 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Metabolic Diseases 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

Tea 2 Bupivacaine 2 Tadalafil 1 Supine Position 1 Morphine 1 Lidocaine 1 Ketamine 1 Injections, Subcutaneous 1 Influenza Vaccines 1 Head-Down Tilt 1 Ethanol 1 Dexmedetomidine 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02998736 2022-12-28

PERIOP-04

Ottawa Hospital Research Institute

Phase 1 Completed

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡